Bellevue Group AG (BBN) - Cash Flow Conversion Efficiency

Latest as of June 2025: 0.150x

Based on the latest financial reports, Bellevue Group AG (BBN) has a cash flow conversion efficiency ratio of 0.150x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CHF16.84 Million ≈ $21.29 Million USD) by net assets (CHF112.53 Million ≈ $142.27 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Bellevue Group AG - Cash Flow Conversion Efficiency Trend (2002–2024)

This chart illustrates how Bellevue Group AG's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read BBN liabilities breakdown for a breakdown of total debt and financial obligations.

Bellevue Group AG Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Bellevue Group AG ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Nyxoah
BR:NYXH
-0.402x
Woorim Machinery Co. Ltd
KQ:101170
-0.035x
Easy Field
TWO:6425
-0.057x
Business Online PCL
BK:BOL
0.012x
Alpha Cognition Inc
NASDAQ:ACOG
-0.158x
Aesler Grup Internasional Tbk Pt
JK:RONY
-1.290x
HYUNDAI FEED Inc
KQ:016790
0.015x
Kyung Nong Corporation
KO:002100
0.043x

Annual Cash Flow Conversion Efficiency for Bellevue Group AG (2002–2024)

The table below shows the annual cash flow conversion efficiency of Bellevue Group AG from 2002 to 2024. For the full company profile with market capitalisation and key ratios, see BBN stock market capitalisation.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 CHF118.52 Million
≈ $149.84 Million
CHF9.40 Million
≈ $11.89 Million
0.079x +9.33%
2023-12-31 CHF122.47 Million
≈ $154.83 Million
CHF8.89 Million
≈ $11.23 Million
0.073x -65.51%
2022-12-31 CHF133.89 Million
≈ $169.27 Million
CHF28.17 Million
≈ $35.61 Million
0.210x -55.77%
2021-12-31 CHF146.59 Million
≈ $185.33 Million
CHF69.73 Million
≈ $88.16 Million
0.476x -46.92%
2020-12-31 CHF165.82 Million
≈ $209.64 Million
CHF148.60 Million
≈ $187.87 Million
0.896x +343.58%
2019-12-31 CHF198.35 Million
≈ $250.77 Million
CHF-72.98 Million
≈ $-92.27 Million
-0.368x -500.65%
2018-12-31 CHF442.17 Million
≈ $559.02 Million
CHF40.61 Million
≈ $51.34 Million
0.092x +65.66%
2017-12-31 CHF425.01 Million
≈ $537.33 Million
CHF23.56 Million
≈ $29.79 Million
0.055x -26.43%
2016-12-31 CHF440.36 Million
≈ $556.73 Million
CHF33.18 Million
≈ $41.95 Million
0.075x +126.22%
2015-12-31 CHF135.96 Million
≈ $171.89 Million
CHF-39.07 Million
≈ $-49.39 Million
-0.287x -928.69%
2014-12-31 CHF402.44 Million
≈ $508.80 Million
CHF-11.24 Million
≈ $-14.21 Million
-0.028x +94.47%
2013-12-31 CHF149.45 Million
≈ $188.95 Million
CHF-75.51 Million
≈ $-95.47 Million
-0.505x -176.98%
2012-12-31 CHF161.21 Million
≈ $203.82 Million
CHF105.81 Million
≈ $133.77 Million
0.656x +1900.24%
2011-12-31 CHF190.63 Million
≈ $241.00 Million
CHF6.25 Million
≈ $7.91 Million
0.033x +105.45%
2010-12-31 CHF294.84 Million
≈ $372.76 Million
CHF-177.59 Million
≈ $-224.53 Million
-0.602x -440.16%
2009-12-31 CHF332.73 Million
≈ $420.66 Million
CHF58.92 Million
≈ $74.49 Million
0.177x -61.43%
2008-12-31 CHF454.64 Million
≈ $574.79 Million
CHF208.73 Million
≈ $263.89 Million
0.459x +8.52%
2007-12-31 CHF478.14 Million
≈ $604.50 Million
CHF202.29 Million
≈ $255.75 Million
0.423x +275.92%
2003-12-31 CHF301.42 Million
≈ $381.08 Million
CHF-72.49 Million
≈ $-91.65 Million
-0.240x -125.99%
2002-12-31 CHF267.98 Million
≈ $338.80 Million
CHF248.01 Million
≈ $313.55 Million
0.925x --

About Bellevue Group AG

SW:BBN Switzerland Asset Management
Market Cap
$127.19 Million
CHF100.61 Million CHF
Market Cap Rank
#18263 Global
#183 in Switzerland
Share Price
CHF7.58
Change (1 day)
-1.30%
52-Week Range
CHF7.10 - CHF12.35
All Time High
CHF38.43
About

Bellevue Group AG provides asset management services in Switzerland, the United Kingdom, Germany, and internationally. The company offers healthcare investment solutions, including biotech, medtech, thematic, and healthcare global and regional. It also provides small and mid-sized entrepreneur investment solutions, such as listed small and mid caps, and private equity strategies; and multi asset,… Read more